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ABSTRACT
The management of pancreaticobiliary disease in patients with surgically altered anatomy is a growing problem for
gastroenterologists today. Over the years, endoscopic ultrasound (EUS) has emerged as an important diagnostic and therapeutic
modality in the treatment of pancreaticobiliary disease. Patient anatomy has become increasingly complex due to advances
in surgical resection of pancreaticobiliary disease and EUS has emerged as the therapy of choice when endoscopic retrograde
cholangiopancreatography failed cannulation or when the papilla is inaccessible such as in gastric obstruction or duodenal
obstruction. The current article gives a comprehensive review of the current literature for EUS-guided intervention of the
pancreaticobiliary tract in patients with altered surgical anatomy.
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INTRODUCTION
The management of pancreaticobiliary disease in
patients with surgically altered anatomy (SAA) is a
growing problem for gastroenterologists today. This
is in part due to the increasing number of patients
undergoing bariatric surgery for obesity, as well as the
increasing number of patients having surgical resections
and palliative procedures for pancreatic, biliary, and
gastric cancers. Common surgical inter ventions
performed for these diseases include Billroth II,
Whipple operation, and Roux-en-Y reconstructions
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either with intact papillae or bilioenteric anastomoses.[1,2]
As the number of patients undergoing these surgeries
continues to increase, gastroenterologists will inevitably
be required to manage a variety of pancreaticobiliary
diseases in patients with SAA.
Endoscopic retrograde cholangiopancreatography
(ERCP) is an essential tool used in the treatment
and diagnosis of pancreaticobiliary disease. ERCP is
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challenging in patients with SAA; the prior interventions
frequently result in long afferent limbs of small bowel
making it difficult to access the papilla. Some of the
common challenges encountered with ERCP in patients
with SAA include excessive looping of the endoscope,
difficulty in accessing the papilla, stenotic anastomotic
sites, and a lack of provider experience in advanced
endoscopic techniques.[3,4] The overall success rate of
ERCP using conventional equipment in patients with
SAA is approximately 51%, with a complication rate as
high as 20%.[5,6]
Given the low success rate and increased complications
of ERCP in patients with SAA, endoscopists have
turned to percutaneous, laparoscopic, and advanced
endoscopic options. Laparoscopic and percutaneous
options are invasive, require coordination of multiple
treatment teams, and have high complication rates
reported at 13%[7] and 25%, respectively.[8,9] Overtubeassisted enteroscopy (OAE) has improved the success
rate of ERCP in patients with SAA; a recent review
examining its use in patients with SAA demonstrated
an overall success rate of 74%.[3] However, given the
variable success rates of OAE-assisted ERCP and the
limited amount of gastroenterologists trained in OAE,
providers continue to search for other options.
Endoscopic ultrasound (EUS) has emerged as an
important diagnostic and therapeutic modality in the
treatment of pancreaticobiliary disease. The use of EUS
to safely gain access to the pancreaticobiliary system
in patients with SAA is growing. As surgically altered
patient anatomy has become increasingly complex, EUS
has emerged as the therapy of choice when ERCP fails
cannulation or when the papilla is inaccessible.

alternative when ERCP fails. The average success
rate of EUS-BD varies from 77% to 94% with a
complication rate of 19%-27%, which is comparable to,
if not better than, PTBD. In addition, it is associated
with lower long-term costs and fewer adverse events.
EUS-BD in patients with SAA can be classified using
the approach taken to achieve access to the biliary
system as well as the direction of the subsequent
intervention. The two approaches used to access the
biliary system are transmural, through the stomach
or bowel wall, or transpapillary. Subsequent biliary
intervention can then be performed using an antegrade
or retrograde approach. Transmural access with a
retrograde approach is commonly referred to as a
rendezvous procedure. Procedures using transmural
access with an antegrade approach fall under the
category of antegrade biliary drainage. More recent
approaches, such as external and internal EUS-directed
transgastric ERCP (external EDGE and internal EDGE)
procedures, have focused more on creating novel
techniques to gain transpapillary access with subsequent
retrograde interventions. Based on a review of current
data, the overall success rate of EUS-guided biliary
drainage, regardless of approach or underlying pathology,
approaches 84%-93%.[4] Here, we will provide a review
of the various techniques and outcomes of EUS-guided
biliary interventions in patients with SAA.
ENDOSCOPIC ULTRASOUND-GUIDED
RENDEZVOUS PROCEDURE

ENDOSCOPIC ULTRASOUND-GUIDED
BILIARY DRAINAGE

In 1996, Wiersema et al. reported using EUS-guided
access to the biliary tree after failed endoscopic
retrograde cholangiography (ERC). Since then, multiple
studies have shown that EUS-rendezvous (EUS-RV) is a
feasible salvage technique to obtain access to the biliary
system after failed ERC.

ERCP is the standard of treatment for most biliary
disorders; however, in patients with SAA, ERCP
is associated with a low success rate and high
complication rate. Reported rates of technical failure
range from 13% to 67%, and rates of perforation and
mortality are approximately 18% and 3%, respectively.
Percutaneous transhepatic biliary drainage (PTBD) is a
reasonable alternative; however, it can lead to external
bile acid loss, as well as significant long-term costs, and
burden to patients and their families. In addition, PTBD
is associated with 0.5%-15% morbidity and 0-4.9%
mortality. Therefore, EUS-BD has surfaced as a feasible

The rendezvous technique is considered as a bridging
procedure in patients with endoscopically accessible
papilla or biliary anastomotic site after failed ERCP
cannulation. EUS-RV can be divided into an
intrahepatic biliary duct (IHBD) approach and an
extrahepatic biliary duct (EHBD) approach. These
techniques achieve biliary access under EUS and
fluoroscopic guidance by creating a temporary biliaryenteric fistula.[9] A fine needle aspiration (FNA) needle
is used to access the biliary system via the stomach
or duodenum. Once accurate placement is achieved,
the guidewire is advanced through the biliary duct
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and ampulla into the duodenum [Figure 1]. ERCP is
reattempted, and biliary cannulation is achieved with the
aid of EUS-placed guidewire [Figure 2].
The overall success rate of EUS-RV is 81% with a
complication rate of 10%. [9] This is comparable for
both IHBD and EHBD approaches. One of the
most challenging aspects of EUS-RV is guidewire
manipulation. The guidewire has to pass through
the long rigid needle, biliary ducts, obstruction, and
ampulla. These challenges are more pronounced with
an IHBD, approach due to the longer distance between
the needle tip and target which decreases the “pushability” of the advancing guidewire. Another challenge
endoscopists face using IHBD approach is successfully
puncturing the biliary ducts, which may be particularly
difficult due to small duct size. Reported failure rate
of IHBD approach by Maranki et al. is around 13%
(five of forty patients). The EHBD approach is from
the duodenum, which decreases the distance between
the biliary access point and target, thus allowing for
better control of the guidewire. The biliary duct with
EHBD approach is also larger; however, the trajectory
tends to favor the liver hilum rather than the distal bile
duct. Ideally, first approach should be EHBD from the
second portion of the duodenum followed by the bulb,
with an IHBD approach reserved for last.
EUS-RV technique is not without complications. One
of the most feared complications in EUS-guided RV
is bile leakage from the punctured biliary duct resulting
in peritonitis. Other complications include pancreatitis,
pneumoperitoneum, sepsis, and abdominal pain. The
combined incidence of these five complications is
around 13%. The EHBD approach is associated with a
greater risk of bile leak than with the IHBD approach.

Figure 1. A guidewire is present in the biliary duct (A) and passing
through the ampulla into the duodenum after endoscopic ultrasoundguided rendezvous procedure

Figure 2. Endoscopic retrograde cholangiopancreatography with
biliary cannulation using an enteroscope (A) is achieved with the aid
of the endoscopic ultrasound placed guidewire via the rendezvous
technique in a patient with a Roux-en-Y gastric bypass

ENDOSCOPIC ULTRASOUND-GUIDED
ANTEGRADE BILIARY DRAINAGE
EUS-antegrade (EUS-AG) is considered in patients who
failed rendezvous ERCP, are poor surgical candidates,
or when rendezvous ERCP is not feasible due to
altered surgical anatomy or outlet obstruction. EUSAG is similar to pancreatic pseudocyst drainage. In
EUS-AG, access to the biliary system is achieved via
an enterobiliary fistula and bypassing cannulation of
the ampulla, as illustrated in Figure 3. Color Doppler
is used to identify any interposing vessels, and IHBD
is punctured from the intestine using an FNA needle
followed by bile aspiration and cholangiography.

Figure 3. Endoscopic ultrasound-guided antegrade biliary drainage
is performed using a linear echoendoscope (A). Under endoscopic
ultrasound guidance, the common bile duct is punctured using a needle (B)
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A guidewire is inserted, and a bougie dilator is used to
dilate the fistula. The guidewire is advanced through the
ampulla or anastomosis with coordinated movements
of the guidewire and dilator inside the biliary system.
Finally, biliary obstruction is relieved via self-expandable
metallic stent or balloon dilation in an antegrade
fashion. All devices are removed following successful
biliary decompression.
Only several reports exist regarding one-step EUS-AG.
The overall success is 77% with a complication rate
of 5%.[7-9] EUS-AG procedure is completed with an
EUS scope alone and does not rely on deep insertion
for access to the biliary orifice. Once the fistula is
dilated with a bougie dilator, the guidewire can be
easily advanced through bile ducts and the ampulla
or anastomosis into the intestine with coordinated
movements of the bougie dilator and the guidewire
inside the biliary system. This is unlike EUS-RV where
only the guidewire enters the biliary system. A major
concern with EUS-AG is bile leak into the peritoneal
cavity through the temporary fistula; however, no cases
of biliary peritonitis have been reported.[10] EUS-AG is
considered as a first-line intervention for patients with
an inaccessible ampulla after failed ERCP, with the
exception of patients with duodenal invasion. Shortterm outcome of EUS-AG for SAA patients has been
promising though no long-term data are available.
ENDOSCOPIC ULTRASOUNDDIRECTED TRANSGASTRIC
ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY
(EUS-DIRECTED TRANSGASTRIC ERCP)
In patients who have undergone Roux-en-Y
reconstruction, successful intubation of the afferent
limb in the Y anastomosis can be particularly
challenging. The long limb that transverses from
gastrojejunal orifice to jejunojejunal anastomosis to
reach the afferent small-bowel limb and the long
limb is often >100 cm. In addition, the angulation of
the jejunojejunal anastomosis can be up to 180° and
adhesions from surgery add to the challenge.
ERCP, with a side-viewing endoscope, in Roux-en-Y
gastric bypass (RYGB) patients, was previously not
considered possible until 1998 when Baron and Vickers
first described this technique using surgical gastrostomy.
Since then, there have been modifications to these
152

methods, most notably the external EDGE procedure
and the internal EDGE procedure.[10]
EXTERNAL EUS-DIRECTED TRANSGASTRIC
ERCP PROCEDURE
The EDGE procedure was first described in the
literature by Kedia et al., in 2014.[10] The procedure is
used for pancreaticobiliary drainage in patients who
have undergone a prior RYGB surgery. The procedure
is done in two stages and involves the placement of
an EUS-assisted percutaneous endoscopic gastrostomy
(PEG) tube with subsequent antegrade ERCP through
the created gastrostomy tract. EUS-assisted PEG tube
placement was first described by Attam et al. as a novel
way to access the gastric remnant in patients with prior
RYGB.[8] Kedia et al. adopted this technique to complete
the first stage of the EDGE procedure.
In the first stage, a linear echoendoscope is used to
endosonographically identify the gastric remnant from
the gastric pouch. The gastric remnant is then accessed
with a needle under EUS guidance through which saline
or air is injected into the remnant stomach to confirm
positioning. A guidewire is then passed through the
EUS needle and coiled in the gastric remnant. A 16 Fr
PEG tube is subsequently placed under fluoroscopic
guidance into the gastric remnant.
The second stage of the procedure is performed
between 3 and 9 days after the first stage. The second
stage involves exchanging the already placed PEG
tube with a transcutaneous fully covered metal stent.
An antegrade ERCP is then performed through the
gastrocutaneous stent allowing for any necessary
pancreaticobiliary drainage. No large-scale clinical
trials have been conducted to assess the success and
complication rates of the EDGE procedure. The largest
case series in the literature includes 6 patients with
RYGB anatomy who underwent EDGE procedure. Five
cases were for cholelithiasis and 1 for biliary stricture.
EUS-guided access into the excluded stomach remnant
was successful in all 6 patients (100%). Antegrade
ERCP was also successfully performed in all 6 patients
(100%). Two patients developed a localized infection at
the site of PEG insertion requiring a course of oral
antibiotics. There were no adverse events associated
with the antegrade ERCP portion of the procedure.
The EDGE procedure is a minimally invasive approach
to obtain pancreaticobiliary access in patients with prior
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RYGB. The major advantages of the procedure include:
A single team can perform the entire procedure, it
is minimally invasive, and the success rate based on
current data has the potential to exceed that of the
other current treatment modalities. The data regarding
the efficacy of the EDGE procedure are currently
limited; however, Kedia et al.’s small case series showed
a 100% success rate of accessing the gastric remnant
and 100% success in performing subsequent antegrade
ERCP. The major downsides of the EDGE procedure
are that it is performed in two stages and requires a
transcutaneous approach. This technique would not
be an option for patients who require immediate
intervention given that the procedure takes a median
of 5.8 days to complete. The procedure also requires
the formation of a transcutaneous gastrostomy tract,
which can cause localized infections, scarring, and fistula
formation. Given that it is a new procedure, the longterm adverse effects of the EDGE procedure have not
yet been realized.
INTERNAL EUS-DIRECTED TRANSGASTRIC
ERCP PROCEDURE
As opposed to the transcutaneous approach of the
external EDGE procedure, the internal EDGE procedure
uses a lumen-opposing metal stent to access the gastric
remnant and perform an antegrade ERCP in a single
endoscopy session. Kedia et al. first introduced the
procedure in 2014 shortly after their case series describing
the external EDGE procedure. Unlike the external
EDGE procedure, the internal EDGE procedure allows
for pancreaticobiliary intervention in a single session. The
first step of the procedure is to identify the excluded
gastric remnant using a linear echoendoscope from the
gastric pouch. Once the gastric remnant is identified, a
19-guage EUS needle is passed from the gastric pouch
into the gastric remnant. Contrast and saline are injected
into the gastric remnant to confirm positioning. A
guidewire is passed into the gastric remnant and using
a 4 mm balloon, the tract is dilated. Following balloon
dilation of the tract, a fully covered lumen-opposing metal
stent (AXIOS stent) is placed across the tract creating a
gastrogastric fistula between gastric pouch and excluded
gastric remnant. The lumen of the stent is dilated to
18 mm using a dilating balloon, which creates a conduit
through which a duodenoscope can be passed and an
antegrade ERCP can be performed. A second endoscopy
is completed weeks after the initial procedure to remove
the lumen-opposing metal stent and repair the remnant
gastric pouch fistula.[10,11]

This novel procedure addresses many of the issues
associated with the external EDGE procedure. The
internal EDGE procedure is completed in a single
session and can achieve urgent pancreaticobiliary
drainage in patients who require immediate intervention.
The internal EDGE procedure is also less invasive.
It eliminates the need to create a transcutaneous
gastrostomy tract, which will reduce cutaneous infection
rates, and eliminate scarring and cutaneous fistula
formation. There is only one case report in the current
literature describing the use of the internal EDGE
procedure and, thus, the data on the effectiveness
and complications associated with the internal EDGE
procedure are very limited. Some of the potential
complications of the Internal EDGE procedure include
stent migration during ERCP, stent migration following
the procedure, postprocedural weight gain with a
maintained gastrogastric fistula, and permanent fistula
formation. More literature is needed to determine the
short- and long-term complications, complication rate,
and success rate of the internal EDGE procedure.
ENDOSCOPIC ULTRASOUND-GUIDED
PANCREATIC DRAINAGE
EUS-pancreatic drainage (EUS-PD) has evolved as an
attractive alternative to surgery and ERCP in patients
with SAA. EUS-PD was first described by Harada
et al. in 1995 and has drastically evolved since then.[12]
Common indications for EUS-PD in patients with SAA
include stenosis of the pancreaticoenterostomy after
pancreaticoduodenectomy (observed in approximately
30% of these patients),[13] pancreatic fistula along with
stenotic pancreaticojejunal (PJ) anastomosis (seen in
10%-20% of Whipple patients),[14-19] acute recurrent
pancreatitis (seen in 2%-3% of Whipple patients),[18,19]
chronic pancreatitis, pancreatic duct strictures, pancreatic
duct stones, and failed ERCP.
Before conducting EUS-PD, both indications
and contraindications of the procedure should
be considered. Relative contraindications include
thrombocytopenia (platelet count <50,000),
coagulopathy (international normalized ratio >1.5),
and hemodynamic instability. Magnetic resonance
cholangiopancreatography has been routinely performed
in many of the case studies and reviews to assist in
characterization of the patient’s anatomy. Prophylactic
intravenous or oral antibiotics are given before the
procedure in case of leakage of gastric, biliary,
pancreatic, or enteric contents and occasionally
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continued for up to 7 days postprocedure.[20-23] Curved
linear array echoendoscopes are routinely used. FNA
needles utilized include 19G, 22G, and 25G. Guidewires
range from 0.018 [24,25] to 0.035 inch [4] but will vary
depending on the gauge of the FNA needle used.
Dilation of the needle tract (using dilation catheters
and/or balloon catheters) is mandatory before stenting
and depends on the size of the pancreatic duct stent.
Plastic stents (5 Fr or 7 Fr) typically used as fully or
partially covered self-expendable metallic stents can
block the pancreatic duct side branches potentially
resulting in pancreatitis. It is vital to identify the
optimal route by which the main pancreatic duct
(MPD) will be accessed. Ideal scenarios include the
shortest distance between EUS transducer and MPD,
lack of structural obstacles (including vasculature), and
optimal angles and pathways for instrumentation and
eventual stent placement.[19] Once MPD is visualized
under EUS guidance, the appropriate FNA needle is
used to transgastrically puncture MPD. Although the
more common route is transgastrically (endoscopic
pancreaticogastrostomy), a transbulbar approach has
also been used (endoscopic pancreaticobulbostomy).[23]
Fluoroscopic verification of MPD access is performed
with contrast injection. A guidewire is then passed
through the FNA needle into MPD under fluoroscopic
guidance.
At this point, PD can be achieved using two different
techniques such as transmural pancreatic duct stenting
(antegrade) or retrograde stenting (rendezvous). [25,26]
With transmural pancreatic duct stenting, the entire
procedure is performed using the echoendoscope with
the stent having to traverse MPD into the stomach.
The transmural pancreatic duct stenting technique,
therefore, requires significant dilation which can result
in adverse events such as pancreatic juice leakage,
pancreatitis, bleeding, and perforation. [25,26] In the
retrograde (rendezvous) approach, MPD is similarly
accessed transgastrically (rarely transduodenally or
transjejunally) under EUS guidance.[4] The guidewire is
advanced through the papilla and into the duodenum,
making sure that there is sufficient looping within
the duodenum to facilitate the next step. The
echoendoscope is then removed; however, the guidewire
remains in place. Subsequently, either a side-viewing
duodenoscope, colonoscope, or balloon enteroscope can
be passed through the gastrojejunostomy to the papilla
and site of anastomosis.[4,24,25] Biopsy forceps are used
to grasp the guidewire, and the papilla can be dilated
accordingly before stent placement. If during the initial
154

steps, the guidewire cannot be passed through the entire
MPD due to structural obstacles (e.g., tight stricture)
or other technical issues (angle of EUS and needle
puncture), the rendezvous method cannot be completed.
A newer technique used to facilitate EUS-PD is
the pancreatic antegrade needle-knife whereby a
cut is made at the PJ anastomosis site, creating a
pancreaticojejunostomy.[23] The pancreaticojejunostomy is
dilated and a long plastic stent (up to 15 cm) is placed
extending from the jejunum to the stomach.[23] Although
data are relatively limited, the technical success rates in
patients with both normal and SAA have been reported
as between 25% and 100% for EUS-guided transmural
pancreatic duct stenting and 77%-92% for the EUSguided rendezvous technique. [26-28] Complications in
all patients have been reported between 10% and
43%. [19,29] A review conducted by Prichard et al. [26]
identified patients with SAA who underwent EUSguided pancreatic duct drainage via either technique.
Many of the studies reviewed were small and included
patients with both normal anatomy and SAA. The
SAA cohorts were especially limited, with most studies
containing <15 SAA patients who underwent any
form of EUS-guided PD. With respect to SAA, there
were considerably more data in post-Whipple patients
compared to those that are postgastric bypass. Many
of the studies did not specifically detail which patients
(normal anatomy vs. SAA) had technical and clinical
success, complications, and exact length of followup; therefore, exact calculation of these rates was
challenging.
Upon further review of the literature, there were
approximately eight studies that had at least seven
patients with SAA. [21-28] As many of the cohorts
contained limited number of patients with varying
medical history, much of the data reported were
heterogeneous. The 96 patients identified underwent
EUS-guided antegrade pancreatic duct stenting and
rendezvous technique at similar rates. The definition
of “technical success” and identification of which
patients with SAA achieved is varied between studies,
but rates ranged from 44% to 100%. Similarly, “clinical
success” had a much more variable definition between
studies and ranged between 22% and 100%. The most
common “mild” complications reported in patients
undergoing EUS-guided PD included abdominal
pain, minor bleeding (controlled with hemoclip),
and pancreatitis with rates between 5.8% and 29%.
Serious complications (e.g., perforation, peripancreatic
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abscesses, and pancreatic juice leakage) ranged from
0% to 12.5%. Median follow-up after the procedure
was between 8 and 47 months (3-108 months). An
interesting postprocedural issue that was reported in
several studies included stent dysfunction and the
requirement for additional procedures. As with the data
mentioned above, many of the studies did not specify
stent dysfunction rates specifically in patients with SAA;
however, rates have been reported as between 25% and
55%.[22,25,29]
Technical and clinical success was impacted by multiple
factors. Many of the studies reported difficulties with
MPD access when it was not dilated.[4,28] Suboptimal
angles during initial attempts at access and tight
strictures within MPD can often lead to passage of the
guidewire into the pancreatic duct side branches.[4,26,28]
Many of the studies reported the need for repeated
attempts at EUS-PD, which could be considered
burdensome to both patient and endoscopist. However,
additional EUS-PD attempts may prove beneficial to
patients as Kikuyama et al. reported increased technical
success rates in this scenario.[22]
The utilization of EUS-PD in patients with SAA is an
evolving technique that is continuing to accumulate data.
Although EUS-PD in patients with SAA requires a high
level of skill and experience, it offers a potentially useful
alternative to surgery or percutaneous intervention in
the patients requiring pancreatic duct decompression.
Additional studies in patients with SAA are needed
to further determine the exact role of EUS-PD and
characterize both efficacy and complication rates
especially with respect to long-term outcomes.
CONCLUSION
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